CMS Open Payments · Program Year 2024
Dynavax Technologies Corporation
Dynavax Technologies Corporation reported $530,474.28 across General Payments, Research, and Ownership to 5,747 physicians and teaching hospitals across 6,129 transactions.
- $530.5K Above-median payer
- All-tracks total
- 6,129 Top quartile volume
- Transactions
- 5,747 Top quartile reach
- Recipients
- +$43.5K
- General Payments vs PY2023
Dynavax Technologies Corporation reported $530,474.28 across all CMS Open Payments tracks (General + Research + Ownership) to 5,747 physicians and teaching hospitals in Program Year 2024 - ranking #746 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $446,227.28, averaging $92.30 per recipient.
How Dynavax Technologies Corporation's $530.5K all-tracks total breaks down
Dynavax Technologies Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
47/100
Total payments
F
15/100
Transaction volume
D
55/100
Physician reach
D
54/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer dynavax-technologies-corporation Dynavax Technologies Corporation
$530.5K · #746/1,925 · 0.0% industry · PY2024
- TOT $530.5K
- RANK #746
- SHARE 0.0%
- TXN 6,129
- RCP 5,747
- CAT 5
- GEN $446.2K
- ΔGEN +$43.5K
- TOP1 62.5%
- PY 2024
Volume peers
Nearest volume peer: OraSure Technologies Inc. ($529.4K)
Dynavax Technologies Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Dynavax Technologies Corporation's CMS-reported General Payments increased by $43.5K (+10.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DYNAVAX TECHNOLOGIES CORPORATIONPY2023: DYNAVAX TECHNOLOGIES CORPORATIONPY2024: Dynavax Technologies Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $402,681.90
- PY2024
- $446,227.28
What the Data Shows for Dynavax Technologies Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Dynavax Technologies Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
66 transactions worth $324.5K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 72.7% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Dynavax Technologies Corporation's 5-category general-payment breakdown at $324.5K, 72.7% of the reported total.
Dynavax Technologies Corporation reports 5 general-payment categories - the top three are Consulting Fee (72.7%), Food and Beverage (24.5%), and Honoraria (1.8%). The remaining 2 categories make up 0.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Dynavax Technologies Corporation divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $324.5K | 66 | 72.7% |
| Food and Beverage | $109.5K | 5,678 | 24.5% |
| Honoraria | $8.3K | 1 | 1.8% |
| Grant | $3.9K | 1 | 0.9% |
| Education | $41.00 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $312,618.83 (70.1%) of $446,227.28 in this company's General Payments records across 3,774 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Dynavax Technologies Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Teck L Ling
$278,688.83 across 51 reported transactions
- 2
Arun Jesudian
$14,580.00 across 1 reported transactions
- 3
Syeda Amna Husain
$8,250.00 across 1 reported transactions
- 4
Walter a Orenstein
$5,600.00 across 1 reported transactions
- 5
Peter a Patriarca
$5,500.00 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Dynavax Technologies Corporation's spend rank (#746 of 1,925, top 39% by spend) and concentration rank (#453 of 1,838, top 25% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Summ Cott Medical : $106.00 total payments, HHI 4021
- Besins Healthcare Ireland Limited : $139.1K total payments, HHI 4012
- Prytime Medical Devices, Inc. : $265.7K total payments, HHI 3997
- Contego Medical, Inc : $340.5K total payments, HHI 3992
- Microgenics Corporation : $106.3K total payments, HHI 3980
- B. Braun Melsungen AG : $165.4K total payments, HHI 3974
- Dynavax Technologies Corporation (this company) : $446.2K total payments, HHI 3923
- Materialise USA LLC : $273.65 total payments, HHI 3922
- Rare Disease Therapeutics, Inc. : $5.6K total payments, HHI 3906
- OraSure Technologies Inc. : $211.4K total payments, HHI 3885
- Gotham Surgical Solutions & Devices, Inc. : $164.9K total payments, HHI 3883
- Surgical Theater. Inc. : $199.9K total payments, HHI 3868
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Dynavax Technologies Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Dynavax Technologies Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Dynavax Technologies Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Pulse Biosciences, Inc.
Veryan Medical Incorporated
GC America Inc.
Astellas Pharma Europe Ltd
OraPharma, a division of Bausch Health US, LLC
Put this to use
Dynavax Technologies Corporation ranks #746 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Dynavax Technologies Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.